1 / 6

Performance & Recovery Research · Longevity Peptides

Adamax Peptide 10mg

~~$140.00~~$70.00Save 50%

Adamax 10mg | Finished in the USA

is a next-generation metabolic research peptide gaining rapid interest for its potential role in appetite modulation, energy balance, glucose regulation, and body-weight studies. As a novel molecule with emerging relevance in obesity and metabolic dysfunction research, Adamax provides a unique pathway distinct from GLP-1 or GIP agonists, allowing researchers to explore alternative mechanisms influencing satiety, caloric intake, neuroendocrine signaling, and adipose behavior.

Build a Pack & Save Up to 20%

Ships in 24 hrs

Free over $250

Adamax Peptide 10mg · 250mcg (100 Capsules)

$70.00$140.00

Recommended with this order

Frequently paired with this compound by other researchers.

50% off

Bacteriostatic Reconstitution Water (BAC)~~$15.00~~$7.50

10ml

For Research Use Only. Not for human consumption or therapeutic treatment.

AboutSpecificationsQuestions

Adamax 10mg | Finished in the USA is a next-generation metabolic research peptide gaining rapid interest for its potential role in appetite modulation, energy balance, glucose regulation, and body-weight studies. As a novel molecule with emerging relevance in obesity and metabolic dysfunction research, Adamax provides a unique pathway distinct from GLP-1 or GIP agonists, allowing researchers to explore alternative mechanisms influencing satiety, caloric intake, neuroendocrine signaling, and adipose behavior. All Adamax vials from Real Peptides are 99%+ purity, third-party tested, and designed for advanced metabolic and endocrine-focused studies.

What Is Adamax?

Adamax is a novel metabolic research peptide studied for its potential to affect appetite, weight regulation, glucose handling, and fat metabolism. While it is not a GLP-1, GIP, or glucagon agonist, Adamax is often investigated alongside advanced GLP peptides like TirzepatideRetatrutideand Survodutide due to overlapping relevance in metabolic and obesity research. Its unique non-GLP mechanism gives researchers a way to expand beyond traditional incretin pathways and explore secondary or adjunctive appetite-control systems.

Why Choose Adamax for Research?

Researchers choose Adamax when they want to look beyond standard GLP-based models while still targeting areas such as appetite signalling, lipid metabolism, and glucose control. Adamax can be incorporated into:

Studies assessing caloric intake behavior
Research examining weight regain after GLP or diet intervention
Comparative experiments against agents like MazdutideTirzepatideor Retatrutide

Stack-based research where Adamax is combined with metabolic enhancers such as 5-Amino-1MQ or mitochondrial peptides like MOTS-c By offering an additional metabolic lever, Adamax lets scientists build more nuanced and layered research designs.

Research observations

Hypothalamic Appetite Signaling

Adamax is being evaluated for its potential impact on appetite-regulating centers in the hypothalamus, where it may modulate neuropeptides tied to hunger and satiety patterns. By altering signal intensity in these circuits, Adamax may help model changes in caloric intake, craving behavior, and feeding frequency in preclinical settings.

Adipocyte Signaling & Fat Oxidation

Studies are exploring whether Adamax can influence fat cell metabolism, including lipolysis, adipocyte size, and fat-storage behavior. Researchers use it in models designed to assess fat oxidation and shifts in energy mobilization from adipose tissue.

Glucose Uptake & Insulin Sensitivity

Adamax is of interest in models examining glucose disposal, insulin sensitivity, and metabolic syndrome. Early research suggests that by modulating metabolic pathways, Adamax may help improve how tissues respond to glucose and insulin signaling, making it relevant in prediabetes and metabolic dysfunction research.

Neuroendocrine Crosstalk

There is strong theoretical interest in Adamax’s role in neuroendocrine communication — the interface between hormones, brain signaling, and behavior. By influencing appetite-related peptides and possibly reward circuits, Adamax can be a useful tool in studying emotional and behavioral components of overeating.

Energy Expenditure & Mitochondrial Activity

Because metabolic rate and mitochondrial function are tightly linked, researchers are also examining Adamax for its potential impact on energy expenditure, basal metabolic rate, and mitochondrial output. This makes it a candidate for multi-pathway obesity and longevity-related studies.

CompoundAdamax Peptide 10mg

Research areaPerformance & Recovery Research, Longevity Peptides, Popular Peptides, Metabolic Peptides, Focus & Cognition Research, Mitochondrial Peptides, Growth Factor & Tissue Signaling Research, Mitochondrial & Metabolic Pathway Research

FormatLyophilised powder, sealed glass vial

Sizes250mcg (100 Capsules)

Reconstituted shelf life30 days at 2–8°C

Independent laboratoryFreedom Diagnostics and Kovera

Ships fromSaint Petersburg, FL and California

DispatchWithin 24 hours

Adamax is a novel metabolic research peptide investigated for its potential impact on appetite regulation, body-weight control, fat metabolism, and glucose handling. Unlike GLP-1 or GIP agonists such as Tirzepatide or Retatrutide, Adamax appears to work through distinct pathways, making it ideal for alternative or adjunctive metabolic research.

Adamax is used in studies focused on hunger modeling, satiety, caloric intake, weight-regain dynamics, metabolic rate, and glucose regulation. It’s often incorporated into complex metabolic research designs that also include agents like Cagrilintide, 5-Amino-1MQ, or GLP-related peptides.

Published research examines Adamax in models of appetite signalling, body-weight trends, energy expenditure, insulin response, and lipid-metabolism pathways, and in comparative work against incretin-based compounds.

Tirzepatide is a dual GIP/GLP-1 agonist with well-defined receptor targets. Adamax, by contrast, appears to function via non-incretin pathways, offering unique insights when studied alongside GLP-1 research peptides in appetite and obesity models.

“Stronger” isn’t the right framing, because Retatrutide is a triple agonist (GLP-1/GIP/glucagon), whereas Adamax follows a different mechanistic route. Researchers instead compare how these compounds differ in appetite reduction, weight maintenance, and metabolic adaptation.

Yes, Adamax is often used in experiments designed to observe changes in hunger, cravings, and feeding patterns, making it a valuable tool in appetite-suppression and caloric-intake research.

Adamax is of particular interest in studies that explore what happens after GLP-1 or GLP-related interventions end. By layering Adamax into these models, researchers can test whether alternative pathways may contribute to weight-maintenance or weight-regain dynamics.

Yes. In research contexts, Adamax is frequently combined with: – Tirzepatide, Retatrutide, Survodutide, Mazdutide – Cagrilintide for amylin-related satiety – 5-Amino-1MQ, MOTS-c, and SS-31 for deep metabolic and mitochondrial research – CJC-1295 no DAC + Ipamorelin or Tesamorelin for recomposition models

Adamax appears to influence hypothalamic appetite circuitry, adipocyte metabolism, neuroendocrine balance, and potentially mitochondrial energy regulation, making it a multi-relevance tool in metabolic and obesity research.

No. Adamax is not a GLP-1, GIP, or glucagon agonist. That’s precisely what makes it valuable — it opens up non-GLP metabolic avenues for researchers who want to look at alternative or complementary mechanisms.

No. Adamax is not FDA approved for any medical or human-use indication. It is available for research use only and should never be used as a treatment, drug, or supplement.

Yes, Adamax may be legally purchased for laboratory research in many regions, provided it is used according to applicable laws and regulations and not administered to humans or animals.

There is no standardized or clinically established human dose. Dosing choices in research settings are based on model type, study duration, and experimental objectives, and are determined by the researchers and ethics committees overseeing the work.

Reconstitution procedures depend on internal lab protocols. Many researchers use sterile diluents such as Bacteriostatic Water following standard peptide-handling and aseptic techniques. Always follow your lab’s SOPs.

Early studies suggest that Adamax may impact glucose-disposal mechanisms and insulin responsiveness, making it a candidate for inclusion in metabolic-syndrome and glycemic-control models alongside compounds like 5-Amino-1MQ or MOTS-c.